LivaNova

LivaNova

World Rank (Aug-2026)
3871
Market Cap (Aug-2026)
4.530 Billion USD
Market Cap (Mar-08-2026)
3.491 Billion USD
World Rank (Jan-05-2024)
4,732
Market Cap (Jan-05-2024)
2.683 Billion USD
World Rank (Jul-30-2023)
4,247
Market Cap (Jul-30-2023)
3.108 Billion USD
World Rank (Jan-07-2022)
3,621
Market Cap (Jan-07-2022)
4.395 Billion USD
World Rank (Jan-01-2021)
4,094
Market Cap (Jan-01-2021)
3.218 Billion USD
Company Rank in Country in 2023
Company rank in UK in July-2023 is 149
Headquarters Country
UK
Top Healthcare Companies in UK
Top Technology Companies in UK
Top Healthcare Companies in Europe
Top Technology Companies in Europe
Nasdaq / NYSE Code
LIVN
Employee Count
4,000
Employee Count as of Date
As on 2020
World Region
Europe
World Subregion
Northern Europe
Annual Revenue in USD
1,388 Million USD
Annual Operating Income in USD
199 Million USD
Annual Net Income in USD
-242 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
2,606 Million USD
Total Liabilities in USD
1,406 Million USD
Total Equity in USD
1,200 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Medical Equipment / Instruments
Technology
HealthCare Products
Company Website
LIVANOVA PLC
Yahoo
Yahoo @ Nasdaq
Company Profile

LivaNova is a Medical Technology company. The company products and therapies are neuromodulation, resources and cardiovascular. It offers a diverse product portfolio with a differentiated pipeline and reach is broad with a presence in more than 100 countries and approximately 4,000 employees. The headquarters is in UK.

Annual Results Summary

LIVANOVA - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-20231,1532117
Dec-20221,02152-86 (Loss)
Dec-20211,035-0.8 (Loss)-135 (Loss)
Dec-2020934-43 (Loss)-345 (Loss)
Dec-20191,08448-155 (Loss)
Balance Sheet Summary

Total Assets as on Dec-2023 was 2,429 Million USD.

Total Liabilities as on Dec-2023 was 1,151 Million USD.

Total Equity as on Dec-2023 was 1,277 Million USD.

Founded Year
1987
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus

Share